|
NETO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31750000000619E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.171600E-01 |
| Normal-vs-Stage2 |
7.900000E-02 |
| Normal-vs-Stage3 |
1.502780E-03 |
| Normal-vs-Stage4 |
4.357600E-02 |
| Stage1-vs-Stage2 |
9.139600E-02 |
| Stage1-vs-Stage3 |
2.995900E-03 |
| Stage1-vs-Stage4 |
6.188400E-02 |
| Stage2-vs-Stage3 |
4.379900E-02 |
| Stage2-vs-Stage4 |
1.598450E-01 |
| Stage3-vs-Stage4 |
7.081400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.554000E-04 |
| Normal-vs-AfricanAmerican |
6.424100E-02 |
| Normal-vs-Asian |
8.285900E-02 |
| Caucasian-vs-AfricanAmerican |
3.006800E-01 |
| Caucasian-vs-Asian |
2.184400E-01 |
| AfricanAmerican-vs-Asian |
1.797590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.138300E-02 |
| Normal-vs-Female |
5.224200E-04 |
| Male-vs-Female |
3.036300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.682400E-02 |
| Normal-vs-Extreme_Weight |
1.522170E-01 |
| Normal-vs-Obese |
6.179800E-03 |
| Normal-vs-Extreme_Obese |
4.900000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.088400E-01 |
| Normal_Weight-vs-Obese |
3.325400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.138800E-01 |
| Extreme_Weight-vs-Obese |
3.568300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.468400E-01 |
| Obese-vs-Extreme_Obese |
4.090000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.365810E-02 |
| Normal-vs-Age(41-60Yrs) |
5.098400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.375600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.122400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.671600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.240000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.183900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.906200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.658400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.340200E-01 |
| Normal-VS-Type2 PRCC |
3.443800E-04 |
| Normal-VS-KIRP CIMP |
2.48889999999724E-05 |
| Normal-VS-Unclassified PRCC |
1.556620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.59019999999811E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.36249999999716E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.259650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.09870000000323E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
6.885200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.64820000000088E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.446400E-02 |
| Normal-vs-N1 |
8.838700E-04 |
| Normal-vs-N2 |
8.915700E-02 |
| N0-vs-N1 |
5.523700E-03 |
| N0-vs-N2 |
6.624100E-02 |
| N1-vs-N2 |
6.799400E-01 |
|
|
